BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s share price reached a new 52-week high during trading on Tuesday . The company traded as high as $1.85 and last traded at $1.75, with a volume of 14381 shares traded. The stock had previously closed at $1.80.
BioRestorative Therapies Stock Down 5.7 %
The firm has a market cap of $2.71 billion, a P/E ratio of -1.54 and a beta of 102.36. The company has a 50 day moving average of $1.59 and a two-hundred day moving average of $1.51.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
See Also
- Five stocks we like better than BioRestorative Therapies
- About the Markup Calculator
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- Trading Stocks: RSI and Why it’s Useful
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.